| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Arrest | 95 | 2024 | 1516 | 12.310 |
Why?
|
| Cardiopulmonary Resuscitation | 84 | 2024 | 996 | 11.050 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 50 | 2024 | 341 | 10.130 |
Why?
|
| Thiamine | 27 | 2024 | 160 | 7.610 |
Why?
|
| Lactic Acid | 28 | 2024 | 1137 | 5.810 |
Why?
|
| Shock, Septic | 22 | 2024 | 771 | 5.770 |
Why?
|
| Hypothermia, Induced | 28 | 2023 | 754 | 4.850 |
Why?
|
| Pyruvate Dehydrogenase Complex | 8 | 2024 | 63 | 3.220 |
Why?
|
| Vasoconstrictor Agents | 18 | 2022 | 653 | 3.090 |
Why?
|
| Sepsis | 28 | 2024 | 2603 | 2.770 |
Why?
|
| Ubiquinone | 6 | 2021 | 181 | 2.480 |
Why?
|
| Emergency Medical Services | 29 | 2023 | 1937 | 2.470 |
Why?
|
| Thiamine Deficiency | 6 | 2024 | 48 | 2.390 |
Why?
|
| Epinephrine | 14 | 2021 | 782 | 2.390 |
Why?
|
| Cytochromes c | 5 | 2019 | 173 | 1.900 |
Why?
|
| Diabetic Ketoacidosis | 5 | 2024 | 252 | 1.820 |
Why?
|
| Hospital Mortality | 39 | 2022 | 5339 | 1.640 |
Why?
|
| Coma | 6 | 2023 | 485 | 1.540 |
Why?
|
| Critical Care | 12 | 2024 | 2713 | 1.490 |
Why?
|
| Adrenergic beta-Agonists | 5 | 2016 | 345 | 1.450 |
Why?
|
| Neuromuscular Blockade | 3 | 2020 | 147 | 1.430 |
Why?
|
| Intensive Care Units | 17 | 2021 | 3799 | 1.430 |
Why?
|
| Body Temperature | 8 | 2021 | 781 | 1.340 |
Why?
|
| Rewarming | 5 | 2021 | 64 | 1.270 |
Why?
|
| Acidosis, Lactic | 6 | 2014 | 144 | 1.160 |
Why?
|
| Anti-Arrhythmia Agents | 9 | 2020 | 772 | 1.140 |
Why?
|
| Electric Countershock | 12 | 2019 | 536 | 1.140 |
Why?
|
| Severity of Illness Index | 17 | 2021 | 15878 | 1.140 |
Why?
|
| Respiratory Insufficiency | 9 | 2017 | 1241 | 1.080 |
Why?
|
| Respiratory Rate | 4 | 2018 | 179 | 1.060 |
Why?
|
| American Heart Association | 13 | 2023 | 1045 | 1.040 |
Why?
|
| Positive-Pressure Respiration | 4 | 2013 | 712 | 1.020 |
Why?
|
| Community-Acquired Infections | 3 | 2019 | 470 | 1.020 |
Why?
|
| Resuscitation | 7 | 2022 | 681 | 1.020 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2018 | 1852 | 1.010 |
Why?
|
| Vitamin B Complex | 7 | 2024 | 299 | 0.970 |
Why?
|
| Emergency Service, Hospital | 29 | 2020 | 7871 | 0.960 |
Why?
|
| Oxygen Consumption | 10 | 2024 | 1872 | 0.940 |
Why?
|
| Intubation, Intratracheal | 8 | 2019 | 1359 | 0.930 |
Why?
|
| Shock | 4 | 2019 | 316 | 0.900 |
Why?
|
| Hypotension | 6 | 2021 | 885 | 0.880 |
Why?
|
| Coronary Artery Bypass | 5 | 2018 | 2188 | 0.860 |
Why?
|
| Humans | 239 | 2024 | 765926 | 0.850 |
Why?
|
| Pulmonary Embolism | 5 | 2020 | 2596 | 0.850 |
Why?
|
| Middle Aged | 124 | 2024 | 223016 | 0.840 |
Why?
|
| Respiration, Artificial | 14 | 2023 | 2726 | 0.820 |
Why?
|
| Critical Illness | 8 | 2023 | 2749 | 0.810 |
Why?
|
| Male | 154 | 2024 | 363815 | 0.810 |
Why?
|
| Aged | 109 | 2024 | 171163 | 0.810 |
Why?
|
| Ascorbic Acid | 4 | 2020 | 657 | 0.790 |
Why?
|
| Propanolamines | 1 | 2022 | 163 | 0.760 |
Why?
|
| Female | 153 | 2024 | 396141 | 0.740 |
Why?
|
| Acute Kidney Injury | 5 | 2023 | 1943 | 0.730 |
Why?
|
| APACHE | 4 | 2021 | 268 | 0.720 |
Why?
|
| Hypothermia | 3 | 2015 | 190 | 0.690 |
Why?
|
| Ventricular Fibrillation | 7 | 2020 | 538 | 0.680 |
Why?
|
| Adrenergic alpha-Agonists | 3 | 2016 | 175 | 0.660 |
Why?
|
| Prone Position | 1 | 2020 | 202 | 0.660 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 1 | 2020 | 144 | 0.660 |
Why?
|
| Nervous System Diseases | 6 | 2018 | 1657 | 0.650 |
Why?
|
| Registries | 31 | 2022 | 8346 | 0.640 |
Why?
|
| Prospective Studies | 48 | 2024 | 54807 | 0.630 |
Why?
|
| Alcoholism | 2 | 2021 | 1978 | 0.630 |
Why?
|
| Blood Circulation | 4 | 2017 | 248 | 0.620 |
Why?
|
| Advanced Cardiac Life Support | 3 | 2020 | 80 | 0.620 |
Why?
|
| Influenza, Human | 2 | 2021 | 1539 | 0.610 |
Why?
|
| Double-Blind Method | 18 | 2024 | 12417 | 0.610 |
Why?
|
| Retrospective Studies | 56 | 2022 | 81537 | 0.590 |
Why?
|
| Fluid Therapy | 5 | 2015 | 587 | 0.590 |
Why?
|
| Patient Positioning | 1 | 2020 | 329 | 0.590 |
Why?
|
| Brain Edema | 2 | 2014 | 601 | 0.590 |
Why?
|
| Perioperative Care | 2 | 2015 | 1042 | 0.580 |
Why?
|
| Intubation | 2 | 2017 | 141 | 0.570 |
Why?
|
| Pneumonia | 3 | 2019 | 2158 | 0.560 |
Why?
|
| Wernicke Encephalopathy | 2 | 2007 | 29 | 0.550 |
Why?
|
| Creatinine | 3 | 2023 | 1916 | 0.550 |
Why?
|
| Hydrocortisone | 5 | 2024 | 1832 | 0.550 |
Why?
|
| Informed Consent | 1 | 2023 | 1010 | 0.550 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2021 | 627 | 0.540 |
Why?
|
| Vomiting | 2 | 2010 | 646 | 0.540 |
Why?
|
| Practice Guidelines as Topic | 18 | 2019 | 7423 | 0.540 |
Why?
|
| Aged, 80 and over | 45 | 2020 | 59496 | 0.540 |
Why?
|
| Fever | 3 | 2015 | 1607 | 0.520 |
Why?
|
| Guidelines as Topic | 2 | 2019 | 1394 | 0.520 |
Why?
|
| Marijuana Abuse | 2 | 2010 | 409 | 0.510 |
Why?
|
| Pulse | 2 | 2018 | 217 | 0.510 |
Why?
|
| Survival Analysis | 15 | 2020 | 10086 | 0.480 |
Why?
|
| Cause of Death | 5 | 2019 | 3715 | 0.480 |
Why?
|
| Vasopressins | 3 | 2021 | 359 | 0.470 |
Why?
|
| Treatment Outcome | 38 | 2024 | 65194 | 0.460 |
Why?
|
| Glycolysis | 1 | 2018 | 837 | 0.450 |
Why?
|
| Survival Rate | 20 | 2021 | 12822 | 0.440 |
Why?
|
| Adult | 68 | 2023 | 223088 | 0.440 |
Why?
|
| Mouth Floor | 1 | 2013 | 39 | 0.430 |
Why?
|
| Wakefulness | 1 | 2020 | 1282 | 0.430 |
Why?
|
| Hemodynamics | 4 | 2022 | 4186 | 0.430 |
Why?
|
| Withholding Treatment | 2 | 2019 | 619 | 0.430 |
Why?
|
| Plethysmography, Whole Body | 1 | 2013 | 25 | 0.430 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2020 | 1881 | 0.420 |
Why?
|
| Carbon Dioxide | 5 | 2023 | 1138 | 0.420 |
Why?
|
| Amiodarone | 5 | 2020 | 216 | 0.420 |
Why?
|
| Ventricular Function | 1 | 2014 | 403 | 0.410 |
Why?
|
| Survivors | 9 | 2023 | 2373 | 0.410 |
Why?
|
| Time Factors | 21 | 2020 | 40097 | 0.400 |
Why?
|
| Micronutrients | 1 | 2015 | 390 | 0.390 |
Why?
|
| Consensus | 12 | 2023 | 3202 | 0.390 |
Why?
|
| Prognosis | 23 | 2021 | 29890 | 0.390 |
Why?
|
| Lung Volume Measurements | 1 | 2013 | 381 | 0.390 |
Why?
|
| Hospitals, Teaching | 2 | 2017 | 1156 | 0.380 |
Why?
|
| Hospitalization | 15 | 2021 | 10810 | 0.380 |
Why?
|
| Bacteremia | 4 | 2012 | 988 | 0.380 |
Why?
|
| Pneumonia, Bacterial | 1 | 2014 | 319 | 0.370 |
Why?
|
| DNA, Mitochondrial | 1 | 2017 | 869 | 0.370 |
Why?
|
| Cardiology | 5 | 2020 | 1696 | 0.370 |
Why?
|
| Airway Management | 4 | 2019 | 325 | 0.370 |
Why?
|
| Logistic Models | 17 | 2019 | 13273 | 0.370 |
Why?
|
| Predictive Value of Tests | 16 | 2018 | 15401 | 0.370 |
Why?
|
| Patient Discharge | 14 | 2021 | 3460 | 0.370 |
Why?
|
| Myoclonus | 1 | 2011 | 107 | 0.360 |
Why?
|
| Emergencies | 4 | 2020 | 1221 | 0.360 |
Why?
|
| Kidney | 4 | 2024 | 7073 | 0.360 |
Why?
|
| ROC Curve | 7 | 2018 | 3612 | 0.360 |
Why?
|
| Lactates | 3 | 2023 | 398 | 0.360 |
Why?
|
| Regional Health Planning | 1 | 2011 | 95 | 0.350 |
Why?
|
| Acid-Base Imbalance | 2 | 2009 | 42 | 0.350 |
Why?
|
| United States | 37 | 2022 | 72909 | 0.340 |
Why?
|
| Vitamins | 3 | 2014 | 1631 | 0.340 |
Why?
|
| Nausea | 2 | 2010 | 678 | 0.340 |
Why?
|
| Defibrillators | 3 | 2020 | 39 | 0.330 |
Why?
|
| Critical Pathways | 1 | 2013 | 475 | 0.330 |
Why?
|
| Pilot Projects | 7 | 2017 | 8724 | 0.330 |
Why?
|
| Length of Stay | 2 | 2015 | 6486 | 0.330 |
Why?
|
| Neuroprotective Agents | 1 | 2016 | 959 | 0.330 |
Why?
|
| Acute Disease | 8 | 2024 | 7236 | 0.320 |
Why?
|
| Flank Pain | 1 | 2009 | 44 | 0.320 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 1276 | 0.310 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2016 | 1568 | 0.300 |
Why?
|
| Microcirculation | 1 | 2013 | 1282 | 0.300 |
Why?
|
| Angiography | 1 | 2013 | 1589 | 0.300 |
Why?
|
| Urinary Tract Infections | 1 | 2014 | 804 | 0.300 |
Why?
|
| Biomedical Research | 1 | 2023 | 3458 | 0.290 |
Why?
|
| Models, Organizational | 1 | 2011 | 548 | 0.290 |
Why?
|
| Postoperative Complications | 4 | 2016 | 15802 | 0.280 |
Why?
|
| Marijuana Smoking | 1 | 2010 | 260 | 0.280 |
Why?
|
| Central Venous Pressure | 1 | 2007 | 80 | 0.280 |
Why?
|
| Cannabinoids | 1 | 2009 | 174 | 0.280 |
Why?
|
| Diabetes Mellitus | 2 | 2024 | 5889 | 0.270 |
Why?
|
| Rhabdomyolysis | 1 | 2007 | 150 | 0.260 |
Why?
|
| Hospitals, Urban | 5 | 2012 | 494 | 0.260 |
Why?
|
| Emergency Treatment | 6 | 2023 | 494 | 0.260 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2015 | 1735 | 0.260 |
Why?
|
| Monitoring, Physiologic | 5 | 2019 | 1793 | 0.260 |
Why?
|
| Leukocyte Count | 1 | 2010 | 1605 | 0.260 |
Why?
|
| Blood Specimen Collection | 1 | 2007 | 238 | 0.260 |
Why?
|
| Lidocaine | 5 | 2020 | 545 | 0.250 |
Why?
|
| Cardiovascular Agents | 3 | 2021 | 848 | 0.240 |
Why?
|
| Beriberi | 1 | 2004 | 6 | 0.240 |
Why?
|
| Oxygen | 3 | 2018 | 4246 | 0.240 |
Why?
|
| Advisory Committees | 4 | 2018 | 796 | 0.240 |
Why?
|
| Randomized Controlled Trials as Topic | 9 | 2024 | 10380 | 0.240 |
Why?
|
| Atropine | 3 | 2020 | 242 | 0.240 |
Why?
|
| Recovery of Function | 4 | 2018 | 2963 | 0.240 |
Why?
|
| Pulmonary Artery | 1 | 2013 | 1937 | 0.230 |
Why?
|
| Cohort Studies | 19 | 2020 | 41680 | 0.230 |
Why?
|
| Intracranial Hemorrhages | 1 | 2010 | 809 | 0.230 |
Why?
|
| Cannabis | 1 | 2010 | 446 | 0.230 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2014 | 20690 | 0.230 |
Why?
|
| Anti-Bacterial Agents | 4 | 2020 | 7473 | 0.220 |
Why?
|
| Infusions, Intravenous | 2 | 2020 | 2227 | 0.220 |
Why?
|
| Mitochondria | 1 | 2017 | 3669 | 0.210 |
Why?
|
| Calcitriol | 2 | 2014 | 299 | 0.210 |
Why?
|
| Dog Diseases | 1 | 2023 | 142 | 0.210 |
Why?
|
| Tidal Volume | 2 | 2017 | 519 | 0.200 |
Why?
|
| Risk Assessment | 9 | 2018 | 24275 | 0.200 |
Why?
|
| Blood Gas Analysis | 4 | 2018 | 382 | 0.200 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2010 | 1022 | 0.200 |
Why?
|
| Patient Care Team | 1 | 2013 | 2515 | 0.200 |
Why?
|
| Cytokines | 3 | 2016 | 7417 | 0.190 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2015 | 3249 | 0.190 |
Why?
|
| Multiple Organ Failure | 3 | 2020 | 389 | 0.190 |
Why?
|
| Cerebrovascular Circulation | 1 | 2011 | 2674 | 0.190 |
Why?
|
| Hospitals | 8 | 2022 | 3886 | 0.180 |
Why?
|
| Glucocorticoids | 2 | 2021 | 2155 | 0.180 |
Why?
|
| Guideline Adherence | 4 | 2019 | 2234 | 0.180 |
Why?
|
| Follow-Up Studies | 10 | 2020 | 39228 | 0.180 |
Why?
|
| Magnesium | 3 | 2019 | 815 | 0.180 |
Why?
|
| Area Under Curve | 7 | 2018 | 1637 | 0.180 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2015 | 694 | 0.180 |
Why?
|
| Pregnancy Complications, Cardiovascular | 3 | 2015 | 518 | 0.180 |
Why?
|
| Statistics, Nonparametric | 3 | 2018 | 2844 | 0.180 |
Why?
|
| Interleukins | 2 | 2016 | 789 | 0.180 |
Why?
|
| Stroke Volume | 1 | 2014 | 5595 | 0.180 |
Why?
|
| Tachycardia, Ventricular | 3 | 2018 | 1313 | 0.180 |
Why?
|
| Methylprednisolone | 1 | 2021 | 386 | 0.170 |
Why?
|
| Troponin I | 1 | 2004 | 656 | 0.170 |
Why?
|
| Triage | 4 | 2009 | 994 | 0.170 |
Why?
|
| Internationality | 2 | 2015 | 1007 | 0.170 |
Why?
|
| Wounds and Injuries | 2 | 2015 | 2513 | 0.170 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2015 | 3682 | 0.170 |
Why?
|
| Young Adult | 12 | 2022 | 59857 | 0.170 |
Why?
|
| Tachycardia | 1 | 2022 | 598 | 0.170 |
Why?
|
| Glasgow Coma Scale | 3 | 2017 | 574 | 0.160 |
Why?
|
| Hospitals, Pediatric | 5 | 2022 | 1850 | 0.160 |
Why?
|
| Adolescent | 18 | 2021 | 88811 | 0.160 |
Why?
|
| Norepinephrine | 1 | 2022 | 898 | 0.160 |
Why?
|
| Hypoxia-Ischemia, Brain | 2 | 2015 | 361 | 0.160 |
Why?
|
| Comorbidity | 7 | 2017 | 10575 | 0.160 |
Why?
|
| Life Support Care | 1 | 2020 | 226 | 0.160 |
Why?
|
| Receptors, Purinergic P2X1 | 1 | 2018 | 8 | 0.160 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2019 | 88 | 0.160 |
Why?
|
| Inflammation | 4 | 2024 | 10843 | 0.160 |
Why?
|
| Multicenter Studies as Topic | 2 | 2024 | 1729 | 0.150 |
Why?
|
| Organizational Case Studies | 1 | 2019 | 301 | 0.150 |
Why?
|
| Sensitivity and Specificity | 6 | 2017 | 14643 | 0.150 |
Why?
|
| Odds Ratio | 9 | 2019 | 9656 | 0.150 |
Why?
|
| Cardiology Service, Hospital | 1 | 2020 | 242 | 0.150 |
Why?
|
| First Aid | 3 | 2023 | 71 | 0.150 |
Why?
|
| Residence Characteristics | 2 | 2019 | 2116 | 0.150 |
Why?
|
| Anaerobiosis | 1 | 2018 | 140 | 0.150 |
Why?
|
| Brain Ischemia | 1 | 2011 | 3000 | 0.150 |
Why?
|
| Heart Failure | 2 | 2019 | 11837 | 0.150 |
Why?
|
| Child | 20 | 2023 | 80568 | 0.150 |
Why?
|
| Vital Signs | 2 | 2017 | 144 | 0.150 |
Why?
|
| Quality of Health Care | 3 | 2013 | 4305 | 0.140 |
Why?
|
| Mitochondria, Heart | 1 | 2019 | 227 | 0.140 |
Why?
|
| Benzoates | 1 | 2019 | 213 | 0.140 |
Why?
|
| Ribonuclease P | 1 | 2017 | 18 | 0.140 |
Why?
|
| Uremia | 1 | 2018 | 202 | 0.140 |
Why?
|
| Hypercapnia | 1 | 2018 | 259 | 0.140 |
Why?
|
| Pancreatitis | 1 | 2024 | 1086 | 0.140 |
Why?
|
| Calcitonin | 1 | 2018 | 326 | 0.140 |
Why?
|
| Hematocrit | 1 | 2018 | 622 | 0.140 |
Why?
|
| Case-Control Studies | 6 | 2017 | 22228 | 0.140 |
Why?
|
| Hyperthermia, Induced | 2 | 2019 | 414 | 0.140 |
Why?
|
| Pregnancy Complications | 1 | 2011 | 2970 | 0.140 |
Why?
|
| Personnel Turnover | 1 | 2017 | 89 | 0.130 |
Why?
|
| Inpatients | 3 | 2019 | 2563 | 0.130 |
Why?
|
| Infant, Newborn | 10 | 2023 | 26380 | 0.130 |
Why?
|
| Balloon Occlusion | 1 | 2017 | 129 | 0.130 |
Why?
|
| Pyrimidinones | 1 | 2019 | 384 | 0.130 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2018 | 389 | 0.130 |
Why?
|
| Drug Therapy, Combination | 3 | 2020 | 6306 | 0.130 |
Why?
|
| Confusion | 1 | 2018 | 278 | 0.130 |
Why?
|
| Gastrointestinal Diseases | 1 | 2004 | 1204 | 0.130 |
Why?
|
| Culture Media | 1 | 2018 | 889 | 0.130 |
Why?
|
| Near Drowning | 1 | 2015 | 11 | 0.130 |
Why?
|
| Protective Agents | 1 | 2017 | 151 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2016 | 3498 | 0.130 |
Why?
|
| Catheterization, Central Venous | 2 | 2015 | 538 | 0.130 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2017 | 191 | 0.130 |
Why?
|
| Coronary Care Units | 1 | 2017 | 235 | 0.130 |
Why?
|
| Hyperoxia | 1 | 2018 | 259 | 0.130 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2018 | 715 | 0.130 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2018 | 1481 | 0.130 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2018 | 621 | 0.130 |
Why?
|
| Prevalence | 6 | 2023 | 15828 | 0.120 |
Why?
|
| Blood Pressure | 3 | 2019 | 8530 | 0.120 |
Why?
|
| Infant | 12 | 2020 | 36426 | 0.120 |
Why?
|
| Injections, Intravenous | 2 | 2014 | 1376 | 0.120 |
Why?
|
| Inappropriate Prescribing | 1 | 2018 | 211 | 0.120 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2015 | 419 | 0.120 |
Why?
|
| Risk Factors | 15 | 2020 | 74850 | 0.120 |
Why?
|
| Hyperglycemia | 3 | 2021 | 1389 | 0.120 |
Why?
|
| Child, Preschool | 12 | 2020 | 42510 | 0.120 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2017 | 215 | 0.120 |
Why?
|
| Quality Improvement | 4 | 2019 | 3847 | 0.120 |
Why?
|
| Disease Management | 2 | 2015 | 2530 | 0.120 |
Why?
|
| Medical Futility | 1 | 2016 | 136 | 0.120 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2015 | 110 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2016 | 4342 | 0.120 |
Why?
|
| Bacterial Infections | 2 | 2020 | 1387 | 0.120 |
Why?
|
| Propensity Score | 6 | 2019 | 1971 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 10727 | 0.110 |
Why?
|
| Hospitals, University | 3 | 2012 | 573 | 0.110 |
Why?
|
| Cardiac Tamponade | 1 | 2015 | 175 | 0.110 |
Why?
|
| Incidence | 5 | 2019 | 21513 | 0.110 |
Why?
|
| Angiopoietin-2 | 1 | 2015 | 186 | 0.110 |
Why?
|
| Magnesium Deficiency | 1 | 2014 | 48 | 0.110 |
Why?
|
| Cardiac Care Facilities | 1 | 2013 | 35 | 0.110 |
Why?
|
| Multivariate Analysis | 5 | 2017 | 12059 | 0.110 |
Why?
|
| Emergency Medicine | 4 | 2007 | 1222 | 0.110 |
Why?
|
| Nitric Oxide | 2 | 2019 | 2141 | 0.110 |
Why?
|
| Myocardial Infarction | 3 | 2023 | 11508 | 0.100 |
Why?
|
| Delivery of Health Care | 1 | 2011 | 5364 | 0.100 |
Why?
|
| PubMed | 1 | 2013 | 130 | 0.100 |
Why?
|
| Naloxone | 1 | 2015 | 373 | 0.100 |
Why?
|
| Simvastatin | 1 | 2015 | 345 | 0.100 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2015 | 314 | 0.100 |
Why?
|
| Renal Dialysis | 2 | 2017 | 1791 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1084 | 0.100 |
Why?
|
| Patients | 1 | 2019 | 908 | 0.100 |
Why?
|
| Hot Temperature | 1 | 2018 | 1433 | 0.100 |
Why?
|
| Confidence Intervals | 2 | 2021 | 2915 | 0.100 |
Why?
|
| Viral Load | 1 | 2021 | 3385 | 0.100 |
Why?
|
| Kidney Failure, Chronic | 1 | 2004 | 2504 | 0.100 |
Why?
|
| Random Allocation | 1 | 2016 | 2394 | 0.090 |
Why?
|
| Disability Evaluation | 1 | 2019 | 1820 | 0.090 |
Why?
|
| Disease Models, Animal | 5 | 2023 | 18292 | 0.090 |
Why?
|
| Arctic Regions | 1 | 2011 | 25 | 0.090 |
Why?
|
| Cell-Derived Microparticles | 1 | 2013 | 160 | 0.090 |
Why?
|
| Dentures | 1 | 2010 | 12 | 0.090 |
Why?
|
| Resuscitation Orders | 1 | 2013 | 271 | 0.090 |
Why?
|
| Treatment Failure | 2 | 2020 | 2653 | 0.090 |
Why?
|
| Partial Pressure | 3 | 2018 | 247 | 0.090 |
Why?
|
| Pandemics | 2 | 2021 | 8721 | 0.090 |
Why?
|
| Baths | 1 | 2010 | 52 | 0.090 |
Why?
|
| Massachusetts | 4 | 2019 | 8882 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2017 | 2350 | 0.090 |
Why?
|
| Respiratory Tract Infections | 1 | 2018 | 1008 | 0.090 |
Why?
|
| Apyrase | 1 | 2013 | 376 | 0.090 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 3851 | 0.090 |
Why?
|
| Dogs | 2 | 2023 | 3824 | 0.080 |
Why?
|
| Coronary Disease | 1 | 2004 | 5919 | 0.080 |
Why?
|
| Cross Infection | 2 | 2020 | 1426 | 0.080 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2010 | 138 | 0.080 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2017 | 1127 | 0.080 |
Why?
|
| Pulmonary Edema | 1 | 2012 | 409 | 0.080 |
Why?
|
| Data Collection | 3 | 2019 | 3318 | 0.080 |
Why?
|
| Vertigo | 1 | 2011 | 205 | 0.080 |
Why?
|
| Urban Health Services | 1 | 2010 | 176 | 0.080 |
Why?
|
| Interleukin-2 | 1 | 2016 | 1894 | 0.080 |
Why?
|
| Acute Lung Injury | 1 | 2013 | 377 | 0.080 |
Why?
|
| Facial Injuries | 1 | 2010 | 190 | 0.080 |
Why?
|
| Risk | 3 | 2016 | 9599 | 0.080 |
Why?
|
| Dietary Supplements | 1 | 2021 | 3427 | 0.080 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2018 | 2255 | 0.080 |
Why?
|
| Calibration | 1 | 2011 | 812 | 0.080 |
Why?
|
| Anaphylaxis | 1 | 2015 | 738 | 0.080 |
Why?
|
| Cell Survival | 1 | 2018 | 5745 | 0.080 |
Why?
|
| Qualitative Research | 1 | 2019 | 3136 | 0.070 |
Why?
|
| Body Temperature Regulation | 2 | 2021 | 291 | 0.070 |
Why?
|
| Coronary Angiography | 2 | 2017 | 4498 | 0.070 |
Why?
|
| Observation | 1 | 2010 | 309 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 1623 | 0.070 |
Why?
|
| Delirium | 1 | 2019 | 1699 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 5 | 2019 | 22327 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2015 | 1404 | 0.070 |
Why?
|
| Hypovolemia | 1 | 2007 | 48 | 0.070 |
Why?
|
| Glucose | 2 | 2019 | 4335 | 0.070 |
Why?
|
| Linear Models | 2 | 2015 | 5873 | 0.070 |
Why?
|
| Algorithms | 2 | 2015 | 14064 | 0.070 |
Why?
|
| Proportional Hazards Models | 3 | 2020 | 12529 | 0.070 |
Why?
|
| Patient Transfer | 1 | 2013 | 789 | 0.070 |
Why?
|
| Foreign Bodies | 1 | 2010 | 402 | 0.070 |
Why?
|
| Antipsychotic Agents | 1 | 2019 | 3075 | 0.070 |
Why?
|
| Cholesterol | 1 | 2015 | 2902 | 0.060 |
Why?
|
| Heart | 1 | 2019 | 4419 | 0.060 |
Why?
|
| Patient Preference | 1 | 2013 | 947 | 0.060 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2010 | 572 | 0.060 |
Why?
|
| Shock, Hemorrhagic | 1 | 2007 | 224 | 0.060 |
Why?
|
| Adrenal Insufficiency | 1 | 2007 | 194 | 0.060 |
Why?
|
| New Jersey | 1 | 2005 | 296 | 0.060 |
Why?
|
| Patient Selection | 1 | 2017 | 4248 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2013 | 2196 | 0.060 |
Why?
|
| Heart Rate | 2 | 2014 | 4203 | 0.060 |
Why?
|
| Tobacco Use Disorder | 1 | 2010 | 708 | 0.060 |
Why?
|
| Physical Exertion | 1 | 2007 | 666 | 0.060 |
Why?
|
| Reference Values | 1 | 2012 | 4909 | 0.060 |
Why?
|
| Animals | 10 | 2023 | 168735 | 0.060 |
Why?
|
| Wounds, Gunshot | 1 | 2010 | 586 | 0.060 |
Why?
|
| Attitude to Health | 1 | 2013 | 2020 | 0.060 |
Why?
|
| Pregnancy | 4 | 2015 | 30230 | 0.060 |
Why?
|
| Asthma | 3 | 2012 | 6268 | 0.060 |
Why?
|
| Thiamine Pyrophosphate | 1 | 2023 | 8 | 0.060 |
Why?
|
| Gram-Negative Bacteria | 2 | 2018 | 274 | 0.060 |
Why?
|
| Age Factors | 3 | 2016 | 18382 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2017 | 8060 | 0.050 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2015 | 2805 | 0.050 |
Why?
|
| Liver Diseases | 1 | 2012 | 1304 | 0.050 |
Why?
|
| Hippocampus | 1 | 2016 | 3772 | 0.050 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2023 | 127 | 0.050 |
Why?
|
| Syncope | 1 | 2006 | 431 | 0.050 |
Why?
|
| Cocaine | 1 | 2007 | 944 | 0.050 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2009 | 806 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2018 | 10426 | 0.050 |
Why?
|
| Cardiac Output | 1 | 2005 | 838 | 0.050 |
Why?
|
| Models, Biological | 1 | 2018 | 9443 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2013 | 4023 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 8603 | 0.050 |
Why?
|
| Age Distribution | 2 | 2019 | 2864 | 0.050 |
Why?
|
| Boston | 3 | 2020 | 9334 | 0.050 |
Why?
|
| Cholesterol, LDL | 1 | 2011 | 2395 | 0.050 |
Why?
|
| Peptides | 1 | 2013 | 4331 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2013 | 3477 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2009 | 1218 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2007 | 2426 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2023 | 1527 | 0.040 |
Why?
|
| Hypernatremia | 1 | 2020 | 78 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 5765 | 0.040 |
Why?
|
| Head | 1 | 2006 | 926 | 0.040 |
Why?
|
| Disease Progression | 1 | 2017 | 13614 | 0.040 |
Why?
|
| Extracorporeal Circulation | 1 | 2019 | 182 | 0.040 |
Why?
|
| Denmark | 1 | 2021 | 774 | 0.040 |
Why?
|
| Mice | 5 | 2019 | 81782 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 8522 | 0.040 |
Why?
|
| Hyponatremia | 1 | 2021 | 278 | 0.040 |
Why?
|
| Respiratory Function Tests | 2 | 2018 | 1692 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2010 | 2901 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 20133 | 0.040 |
Why?
|
| Neurologic Examination | 1 | 2021 | 913 | 0.040 |
Why?
|
| Syndrome | 1 | 2004 | 3271 | 0.040 |
Why?
|
| Early Diagnosis | 2 | 2017 | 1186 | 0.040 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2018 | 168 | 0.040 |
Why?
|
| Depressive Disorder | 1 | 2010 | 3712 | 0.040 |
Why?
|
| Bicarbonates | 1 | 2019 | 293 | 0.040 |
Why?
|
| HLA-DR Antigens | 1 | 2019 | 608 | 0.040 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2012 | 3247 | 0.040 |
Why?
|
| Stroke | 3 | 2019 | 9739 | 0.040 |
Why?
|
| Research Design | 1 | 2013 | 6204 | 0.040 |
Why?
|
| Gram-Positive Bacteria | 1 | 2018 | 179 | 0.040 |
Why?
|
| Placebos | 1 | 2021 | 1659 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2017 | 6321 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2018 | 507 | 0.030 |
Why?
|
| Temperature | 1 | 2023 | 2226 | 0.030 |
Why?
|
| Acidosis | 1 | 2018 | 271 | 0.030 |
Why?
|
| Uncertainty | 1 | 2021 | 763 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2018 | 565 | 0.030 |
Why?
|
| Heart Massage | 1 | 2015 | 32 | 0.030 |
Why?
|
| Surgery Department, Hospital | 1 | 2017 | 170 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 2011 | 4544 | 0.030 |
Why?
|
| Hospital Units | 1 | 2016 | 141 | 0.030 |
Why?
|
| Ventilators, Mechanical | 1 | 2018 | 291 | 0.030 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2010 | 3719 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2016 | 615 | 0.030 |
Why?
|
| Telemetry | 1 | 2016 | 201 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2002 | 1404 | 0.030 |
Why?
|
| Brain Damage, Chronic | 1 | 2015 | 265 | 0.030 |
Why?
|
| Systems Analysis | 1 | 2015 | 168 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 15645 | 0.030 |
Why?
|
| Cathelicidins | 1 | 2014 | 81 | 0.030 |
Why?
|
| Endoscopy, Digestive System | 1 | 2017 | 358 | 0.030 |
Why?
|
| Hospitalists | 1 | 2018 | 297 | 0.030 |
Why?
|
| Medical Records | 1 | 2019 | 1408 | 0.030 |
Why?
|
| Models, Theoretical | 2 | 2018 | 3560 | 0.030 |
Why?
|
| Child, Hospitalized | 1 | 2015 | 181 | 0.030 |
Why?
|
| Reference Standards | 1 | 2017 | 1011 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 12973 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2015 | 583 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2019 | 2075 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2018 | 1818 | 0.030 |
Why?
|
| Judgment | 1 | 2015 | 270 | 0.030 |
Why?
|
| Electrocardiography | 2 | 2017 | 6409 | 0.030 |
Why?
|
| Drug Repositioning | 1 | 2015 | 244 | 0.030 |
Why?
|
| Obesity | 2 | 2012 | 13082 | 0.030 |
Why?
|
| International Cooperation | 1 | 2019 | 1433 | 0.030 |
Why?
|
| Coronary Circulation | 1 | 2019 | 1601 | 0.030 |
Why?
|
| Swine | 1 | 2023 | 5986 | 0.030 |
Why?
|
| Bacterial Toxins | 1 | 2018 | 924 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2019 | 2219 | 0.030 |
Why?
|
| Hypoxia, Brain | 1 | 2013 | 139 | 0.030 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2013 | 123 | 0.020 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2015 | 373 | 0.020 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2014 | 348 | 0.020 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2017 | 1097 | 0.020 |
Why?
|
| Patient Admission | 1 | 2018 | 1365 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 3801 | 0.020 |
Why?
|
| Dyspnea | 1 | 2019 | 1351 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2017 | 934 | 0.020 |
Why?
|
| Half-Life | 1 | 2012 | 645 | 0.020 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2018 | 1021 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 21069 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2017 | 1740 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2019 | 1590 | 0.020 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2012 | 239 | 0.020 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2013 | 388 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2013 | 699 | 0.020 |
Why?
|
| Respiratory Aspiration | 1 | 2010 | 89 | 0.020 |
Why?
|
| Acetaminophen | 1 | 2013 | 549 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 3690 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2019 | 8279 | 0.020 |
Why?
|
| Anxiety | 1 | 2023 | 4669 | 0.020 |
Why?
|
| Cosyntropin | 1 | 2007 | 34 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2018 | 2596 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2019 | 3953 | 0.020 |
Why?
|
| Tissue and Organ Procurement | 1 | 2015 | 988 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 1886 | 0.020 |
Why?
|
| Injury Severity Score | 1 | 2010 | 1049 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 2782 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 4851 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2010 | 1835 | 0.020 |
Why?
|
| Calcium | 1 | 2019 | 5769 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2015 | 1919 | 0.020 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2012 | 704 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 2108 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2015 | 2170 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2017 | 4423 | 0.020 |
Why?
|
| Urea | 1 | 2007 | 449 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2007 | 1607 | 0.010 |
Why?
|
| Vitamin D | 1 | 2018 | 3272 | 0.010 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2005 | 87 | 0.010 |
Why?
|
| Recurrence | 1 | 2017 | 8492 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 5531 | 0.010 |
Why?
|
| Health Status | 1 | 2017 | 4085 | 0.010 |
Why?
|
| Forecasting | 1 | 2013 | 2936 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2012 | 4016 | 0.010 |
Why?
|
| Hormones | 1 | 2007 | 865 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2019 | 14450 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 2007 | 646 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 2012 | 1392 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2013 | 2331 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2017 | 5088 | 0.010 |
Why?
|
| Seizures | 1 | 2015 | 2997 | 0.010 |
Why?
|
| Perfusion | 1 | 2007 | 1408 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2014 | 3078 | 0.010 |
Why?
|
| Rats | 1 | 2018 | 23708 | 0.010 |
Why?
|
| Probability | 1 | 2007 | 2474 | 0.010 |
Why?
|
| Suicide, Attempted | 1 | 2010 | 1412 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2012 | 2969 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2015 | 6422 | 0.010 |
Why?
|
| Causality | 1 | 2007 | 1247 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 3405 | 0.010 |
Why?
|
| Phenotype | 1 | 2018 | 16714 | 0.010 |
Why?
|
| Decision Making | 1 | 2013 | 3955 | 0.010 |
Why?
|
| Physicians | 1 | 2017 | 4591 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2009 | 5300 | 0.010 |
Why?
|
| Liver | 1 | 2013 | 7559 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2017 | 5945 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2007 | 6503 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 26282 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 36547 | 0.000 |
Why?
|